Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)
暂无分享,去创建一个
I. Pollack | P. Phillips | G. Grant | M. Fouladi | A. Onar-Thomas | S. Gururangan | D. Mitchell | J. Boyett | R. Schmittling | P. Baxter | E. Reap | M. Koçak | Renee M. Reynolds | Renée Reynolds
[1] Deborah S. Barkauskas,et al. Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity , 2016, Science.
[2] I. Pollack,et al. MB-94IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11) , 2016 .
[3] Z. Amoura,et al. Regulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus Erythematosus , 2015, PloS one.
[4] L. Coussens,et al. Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance. , 2015, Trends in cancer.
[5] Christopher M. Jackson,et al. Immunotherapy for Brain Cancer: Recent Progress and Future Promise , 2014, Clinical Cancer Research.
[6] C. Yee,et al. The Effect of Radiation on the Immune Response to Cancers , 2014, International journal of molecular sciences.
[7] Daofeng Liu,et al. Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. , 2013, Clinical immunology.
[8] D. Wainwright,et al. Targeting Tregs in Malignant Brain Cancer: Overcoming IDO , 2013, Front. Immunol..
[9] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[10] David E. Anderson,et al. Medulloblasoma: challenges for effective immunotherapy , 2012, Journal of Neuro-Oncology.
[11] J. Lederer,et al. Targeting regulatory T cells in cancer. , 2011, Cancer research.
[12] D. Mougiakakos,et al. Camouflage and sabotage: tumor escape from the immune system , 2011, Cancer Immunology, Immunotherapy.
[13] D. Schadendorf,et al. Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] P. Zhou,et al. The Role of T-Helper 17 (Th17) Cells in Patients with Medulloblastoma , 2010, The Journal of international medical research.
[15] R. McLendon,et al. Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. , 2008, Neuro-oncology.
[16] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[17] G. Fuller,et al. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. , 2008, Clinical neurosurgery.
[18] G. Basso,et al. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. , 2007, Cancer research.
[19] J. McCune,et al. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. , 2007, Journal of immunological methods.
[20] T. Merchant,et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.
[21] W. Zou,et al. Regulatory T-cell compartmentalization and trafficking. , 2006, Blood.
[22] A. Friedman,et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. , 2006, Cancer research.
[23] C. Kruchko,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.
[24] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[25] J. Ashwell,et al. Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.